Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey
Salihoglu, A., Elverdi, T., Karadogan, I., Paydas, S., Ozdemir, E., Erdem, G., Karadurmus, N., Akyol, G., Kaynar, L., Yegin, ZA, Sucak, G., Ozkocaman, V., Topcuoglu, P., Ozcan, M., Birtas, E., Goker, H., Baslar, Z., Ferhanoglu, B.
Published in Annals of hematology (01.03.2015)
Published in Annals of hematology (01.03.2015)
Get full text
Journal Article
PB1899: DEVELOPMENT AND VALIDATION OF A PREDICTIVE SCORING SYSTEM FOR THE PROGNOSIS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) IN CHRONIC PHASE RECEIVING FIRST‐LINE IMATINIB
Bektaş, M., Eşkazan, A. E., Tiryaki, T. O., Mullai, R., Elverdi, T., Salihoğlu, A., Tiribelli, M., Ar, M. C., Öngören, S., Başlar, Z., Nalçaci, M., Soysal, T.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
IgD Multiple Myeloma, Descriptive Report of Eight Cases, Single Centre Experience
Ongoren, S, Erdogan, I, Salihoglu, A, Elverdi, T, Yalniz, F.F, Berk, S, Sadri, S, Keskin, D, Yurttas, N.O, Eskazan, A.E, Ar, M.C, Baslar, Z, Soysal, T, Aydin, Y
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
Carfilzomib in Relapsed/Refractory Multiple Myeloma, Single Center Experience
Aydin, Y, Erdogan, I, Salihoglu, A, Elverdi, T, Yalniz, F.F, Berk, S, Sadri, S, Keskin, D, Eskazan, A.E, Ar, M.C, Ongoren, S, Baslar, Z, Soysal, T
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
Treatment Responses, Toxicity, and Survival in Patients with Classical Hodgkin Lymphoma Aged ≥50 Years: A Single-Center Experience Over Two Decades
Çokgezer, Simay, Elverdi, Tuğrul, Salihoğlu, Ayşe, Ar, Muhlis Cem, Öngören, Şeniz, Başlar, Zafer, Eşkazan, Ahmet Emre
Published in Cancer management and research (30.06.2022)
Published in Cancer management and research (30.06.2022)
Get full text
Journal Article
PB1904 PROPHYLAXIS FOR OCCULT HBV INFECTION UNDER IBRUTINIB THERAPY: MANDATORY OR OPTIONAL?
Ercaliskan, A., Eskazan, A.E., Salihoglu, A., Keskin, D., Ozmen, D., Elverdi, T., Ar, M.C., Soysal, T.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article
PB1929 POTENTIAL DRUG‐DRUG INTERACTIONS AMONG PATIENTS WITH CHRONIC MYELOID LEUKEMIA UNDER TYROSINE KINASE INHIBITOR THERAPY WITH IMATINIB
Kunbaz, A., Eskazan, A.E., Ozmen, D., Sasmaz, A., Hakmi, A., Shahab, S., Elverdi, T., Salihoglu, A., Ar, M.C., Soysal, T.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article
Tuberculosis After Hematopoietic Stem Cell Transplantation: Retrospective Study of Infectious Diseases Working Party EBMT
Drozd-Sokolowska, J, Tridello, G, Kozijn, AE, Karakukcu, M, Ben Abdeljelil, N, Kroger, N, Passweg, J, Aljurf, M, Colita, A, Atay, D, Tanase, A, Vazquez, L, Piekarska, A, Faraci, M, Elverdi, T, Carlson, K, McQuaker, G, Snowden, JA, Labussiere-Wallet, H, Patrick, K, Jindra, P, Al Zahrani, M, Bolaman, Z, Waszczuk-Gajda, A, Baurmann, H, Krivan, G, Broers, AEC, Blennow, O, Basak, GW, Knelange, N, Averbuch, D, Gil, L, Mikulska, M, Styczynski, J
Published in BONE MARROW TRANSPLANTATION (2020)
Get full text
Published in BONE MARROW TRANSPLANTATION (2020)
Conference Proceeding